#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Candida infection PIK3CA-activated mutation Cervix carcinoma recurrent Friedreich's ataxia B-cell lymphoma recurrent Thrombotic thrombocytopenic purpura Gastrointestinal cancer metastatic Piriformis syndrome Polyneuropathy T-cell lymphoma Facioscapulohumeral muscular dystrophy Anti-myelin-associated glycoprotein associated polyneuropathy Angiosarcoma Synovial sarcoma recurrent Glioma More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Trials in Disease Ewing’s sarcoma Hereditary optic atrophy – Life with Disease Lennox-Gastaut syndrome – Treatment Osteosarcoma metastatic – Treatment Epidermolysis bullosa – Life with Disease Pleural mesothelioma malignant – Diagnostics Carcinoid syndrome – Basic Information Medulloblastoma recurrent – Treatment Glomerulonephritis rapidly progressive – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lolium Perenne Fosfomycin Valiltramiprosate Betula Pendula Pollen Extract Satralizumab Nemtabrutinib Peginterferon Beta-1A Nitrogen Elebsiran Amiloride Tramadol Quavonlimab Moxifloxacin Hydrochloride Gabapentin Damoctocog Alfa Pegol Lisocabtagene Maraleucel Ramipril AGA2118 Efpegerglucagon Lisinopril Dihydrate More therapies…

    Learn about Your Condition

    Menopausal symptoms Small cell carcinoma Sinus rhythm Carotid arteriosclerosis Chondrosarcoma metastatic Metabolic surgery Aplasia pure red cell Angiopathy Neuromyopathy Blood disorder Leukoencephalopathy Renal injury Albright's disease Immune-mediated renal disorder Hypercholesterolaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Deafness neurosensory

  • Study on the Effects of Intracochlear Triamcinolone Acetonide for Patients with Persistent Sudden Sensorineural Hearing Loss After Unsuccessful Conservative Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Deafness neurosensory
    • Deafness
    Investigated Drugs:
    • Triamcinolone Acetonide
    Austria

  • Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Deafness neurosensory
    Investigated Drugs:
    • Nitrous Oxide
    • Oxygen
    Norway

  • Study on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deafness neurosensory
    Investigated Drugs:
    • 6-Fluoro-9-Methyl-9H-Pyrido[3,4-B]-Indole
    • Prednisolone
    Austria Czechia Germany The Netherlands Poland

  • Study on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin

    Not recruiting

    2 1
    Investigated Diseases:
    • Deafness neurosensory
    Investigated Drugs:
    • Acou085
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!